ArticleBiomaterials2019

Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.

Kristen L Kozielski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.